The medical device company allegedly paid physicians, medical practices and hospitals to encourage use of its products for uterine fibroid embolizations and other embolization procedures over a six-year scheme, the statement said. Despite claiming the payments were made to “increase awareness” of the treatments, the company allegedly only sent assistance to select providers.
“Merit Medical provided millions of dollars of advertising and other marketing support to healthcare providers to induce sales of its products,” Assistant U.S. Attorney Rachael Honig said in a statement. “Unlawful kickbacks like these distort the market for medical devices upon which our healthcare system depends.”
On top of the settlement payment, Merit Medical must hire a compliance expert and an independent review organization as part of a five-year corporate integrity agreement, the statement said.
Read full details here.
More articles on devices:
How Medtronic plans to accelerate revenue growth, win share — 5 key strategies
Intermountain’s AI system helps surgeons reduce costs, improve outcomes
NuVasive reorganizes to execute strategy, growth goals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.